G E Goodman

Summary

Affiliation: Swedish Medical Center
Country: USA

Publications

  1. ncbi Biorepositories: let's not lose what we have so carefully gathered!
    Gary E Goodman
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Epidemiol Biomarkers Prev 15:599-601. 2006
  2. ncbi The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements
    Gary E Goodman
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, Bldg M, M1 B514, Seattle, WA 98109, USA
    J Natl Cancer Inst 96:1743-50. 2004
  3. ncbi The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial
    Gary E Goodman
    The Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer Epidemiol Biomarkers Prev 12:518-26. 2003
  4. ncbi Lung cancer. 1: prevention of lung cancer
    G E Goodman
    Fred Hutchinson Cancer Research Center, Swedish Medical Center Cancer Institute, Seattle, Washington, USA
    Thorax 57:994-9. 2002
  5. ncbi Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk
    G E Goodman
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer Epidemiol Biomarkers Prev 10:1069-76. 2001
  6. ncbi Prevention of lung cancer
    G E Goodman
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Crit Rev Oncol Hematol 33:187-97. 2000
  7. ncbi Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Beta-Carotene and Retinol Efficacy Trial
    G E Goodman
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer Epidemiol Biomarkers Prev 7:405-12. 1998
  8. ncbi Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer
    W J Ellis
    Division of Public Health Services, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA
    J Urol 166:93-8; discussion 98-9. 2001
  9. ncbi Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
    N Scholler
    Pacific Northwest Research Institute, 720 Broadway, Seattle, WA 98122, USA
    Proc Natl Acad Sci U S A 96:11531-6. 1999
  10. ncbi Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort
    Margaret R Spitz
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer Epidemiol Biomarkers Prev 11:1413-8. 2002

Collaborators

Detail Information

Publications28

  1. ncbi Biorepositories: let's not lose what we have so carefully gathered!
    Gary E Goodman
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Cancer Epidemiol Biomarkers Prev 15:599-601. 2006
  2. ncbi The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements
    Gary E Goodman
    Fred Hutchinson Cancer Research Center, 1100 Fairview Ave North, Bldg M, M1 B514, Seattle, WA 98109, USA
    J Natl Cancer Inst 96:1743-50. 2004
    ....
  3. ncbi The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial
    Gary E Goodman
    The Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer Epidemiol Biomarkers Prev 12:518-26. 2003
    ..There was no statistically significant association between serum carotenoids and prostate cancer. Our findings provide additional support for the association between physiological levels of dietary micronutrients and cancer incidence...
  4. ncbi Lung cancer. 1: prevention of lung cancer
    G E Goodman
    Fred Hutchinson Cancer Research Center, Swedish Medical Center Cancer Institute, Seattle, Washington, USA
    Thorax 57:994-9. 2002
    ..It is predicted that greater success in chemoprevention will be achieved in the next decade than in the last...
  5. ncbi Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk
    G E Goodman
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer Epidemiol Biomarkers Prev 10:1069-76. 2001
    ..In the CARET population of current and former smokers consuming an ad libitum diet, the serum concentration of selenium was not a risk factor for either lung cancer or prostate cancer...
  6. ncbi Prevention of lung cancer
    G E Goodman
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Crit Rev Oncol Hematol 33:187-97. 2000
    ..Trials are underway to determine what are appropriate surrogate endpoints for lung cancer chemoprevention trials...
  7. ncbi Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Beta-Carotene and Retinol Efficacy Trial
    G E Goodman
    Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Cancer Epidemiol Biomarkers Prev 7:405-12. 1998
    ..A major limitation of this study was that the pool of minorities that was reached was small...
  8. ncbi Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer
    W J Ellis
    Division of Public Health Services, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington, USA
    J Urol 166:93-8; discussion 98-9. 2001
    ....
  9. ncbi Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
    N Scholler
    Pacific Northwest Research Institute, 720 Broadway, Seattle, WA 98122, USA
    Proc Natl Acad Sci U S A 96:11531-6. 1999
    ..Soluble molecules of the mesothelin/MPF family may provide useful new marker(s) for diagnosis of ovarian carcinoma and/or monitoring its response to therapy...
  10. ncbi Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort
    Margaret R Spitz
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer Epidemiol Biomarkers Prev 11:1413-8. 2002
    ..Finally, from these data, we cannot exclude the possibility that risk of lung cancer in nonsmokers may be related to IGF-I levels...
  11. ncbi Evidence for excess colorectal cancer incidence among asbestos-exposed men in the Beta-Carotene and Retinol Efficacy Trial
    Oluremi A Aliyu
    Cancer Center, Yale University School of Medicine, New Haven, CT, USA
    Am J Epidemiol 162:868-78. 2005
    ..Nonetheless, these data suggest that colorectal cancer risk is elevated among men occupationally exposed to asbestos, especially those with evidence of nonmalignant asbestos-associated radiographic changes...
  12. ncbi Serum trans-fatty acids are associated with risk of prostate cancer in beta-Carotene and Retinol Efficacy Trial
    Irena B King
    Cancer Prevention Program, Division of Public Health Sciences, Public Health Sciences Laboratories, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Suite M 5A864, Seattle WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 14:988-92. 2005
    ..Additional studies are needed to confirm these findings and better control for factors, such as use of prostate-specific antigen screening, which may confound this association...
  13. ncbi Predictors of lung cancer among asbestos-exposed men in the {beta}-carotene and retinol efficacy trial
    Mark R Cullen
    Occupational and Environmental Medicine Program and the Cancer Center, Yale University School of Medicine, New Haven, CT 06510, USA
    Am J Epidemiol 161:260-70. 2005
    ..Residual confounding by subclinical asbestosis, exposure to unmeasured lung carcinogens, or differences in smoking are unlikely to explain these observations better than a carcinogenic effect of asbestos per se...
  14. ncbi Physical activity in relation to all-site and lung cancer incidence and mortality in current and former smokers
    Catherine M Alfano
    Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M3-B232, Seattle, WA 98109-1024, USA
    Cancer Epidemiol Biomarkers Prev 13:2233-41. 2004
    ..Prospective studies using more sophisticated measures of physical activity assessed at multiple time points during follow-up are needed to corroborate these associations...
  15. ncbi Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers
    Ji Yeob Choi
    Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Elm and Carlton Sts, Buffalo, NY 14263, USA
    Cancer Epidemiol Biomarkers Prev 16:1115-20. 2007
    ....
  16. ncbi Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokers
    Jason W Chien
    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    COPD 4:339-46. 2007
    ..These data indicate an FEV(1)/FVC<0.7 among smokers is significantly associated with faster airflow loss, and an increased risk for developing lung cancer, even among those individuals with a normal FEV(1)...
  17. ncbi Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial
    Chu Chen
    Program in Epidemiology, Fred Hutchinson Cancer Research Center, and Department of Epidemiology, University of Washington, Seattle, 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 12:1410-6. 2003
    ..The suggestions that intraprostatic androgen activity may increase risk and that serum estrogens may decrease risk, warrant additional study...
  18. ncbi Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET)
    Marian L Neuhouser
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 12:350-8. 2003
    ..However, persons who use beta-carotene supplements do not benefit from the protective compounds in plant foods...
  19. ncbi Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort
    Ji Yeob Choi
    Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA
    Carcinogenesis 29:964-70. 2008
    ..These findings suggest that higher iron intake may be associated with risk of clinically aggressive prostate cancer, and that endogenous antioxidant capabilities may modify these associations...
  20. ncbi V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk
    Inbal Boger-Megiddo
    Program in Epidemiology, Division of Public Health, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 17:286-91. 2008
    ..However, the absence of an overall association between V89L genotype and aggressive prostate cancer argues for a cautious interpretation of these observations...
  21. ncbi A mouse to human search for plasma proteome changes associated with pancreatic tumor development
    Vitor M Faca
    Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
    PLoS Med 5:e123. 2008
    ....
  22. ncbi Multigene real-time PCR detection of circulating tumor cells in peripheral blood of lung cancer patients
    Dawn C Hayes
    GSK Biologicals Seattle, 1900 9th Avenue, Suite 1100, Seattle, WA 98101 USA
    Anticancer Res 26:1567-75. 2006
    ....
  23. ncbi Chlamydia pneumoniae infection and risk of lung cancer
    Alyson J Littman
    Department of Epidemiology, University of Washington, 1100 Fairview Avenue North, PO Box 19024, Seattle 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 13:1624-30. 2004
    ..Future studies using precise measures of chronic C. pneumoniae status are needed to better determine the role of this organism in the etiology of lung cancer...
  24. ncbi Prior lung disease and risk of lung cancer in a large prospective study
    Alyson J Littman
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    Cancer Causes Control 15:819-27. 2004
    ..Identifying factors that increase a smoker's risk of developing lung cancer may help scientists to better understand the etiology of lung cancer and more effectively target high-risk groups for screening...
  25. ncbi Flow cytometric enrichment for respiratory epithelial cells in sputum
    Petra S Kraemer
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA
    Cytometry A 60:1-7. 2004
    ..With further development, this methodology may be useful as part of a molecular screening approach of populations at high risk for lung cancer...
  26. ncbi Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study
    David Z J Chu
    City of Hope National Medical Center, Duarte, California, USA
    Ann Surg Oncol 10:870-5. 2003
    ..Patients with higher rates of adenoma recurrences, such as CRC with synchronous adenomas, are ideal subjects for chemoprevention trials...
  27. ncbi Streamlining IRB review in multisite trials through single-study IRB Cooperative Agreements: experience of the Beta-Carotene and Retinol Efficacy Trial (CARET)
    Mark D Thornquist
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Control Clin Trials 23:80-6. 2002
    ..We describe our experience and make recommendations for other multisite clinical trials...
  28. ncbi Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera
    Ji Qiu
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    J Clin Oncol 26:5060-6. 2008
    ....